Shockwave Medical (SWAV) executive Godshall sold 5,000 shares for $939K at an average $187.80 under a 10b5-1 plan
Insider transactions reported
Douglas Evan Godshall (executive at Shockwave Medical Inc., SWAV) reported that they sold 5,000 shares for $939K at an average $187.80, and acquired 5,000 shares at $3.42 on Dec 15, 2023. After these transactions the filing shows 141,057 shares held directly.
- Reporting person
- Godshall Douglas Evan
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 15, 2023 | Exercise or conversion of a derivative (M) | Common Stock1 | +5,000 | $3.42 | $17.1K | 146,057 direct |
| Dec 15, 2023 | Open-market sale (S) | Common Stock1, 2, 3, ... | -5,000 | avg $187.80 | $939K | 141,057 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 15, 2023 | Exercise or conversion of a derivative (M) | Stock OptionOn 5,000 Common Stock1, 7 | -5,000 | - | - | 324,799 direct |
Holdings before and after
- Stock Option: 329,799 to 324,799 direct
Footnotes from the filing
- 1. All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/25/2023.
- 2. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $186.24 to $187.22. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- 7. Fully vested.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Godshall report in this SWAV Form 4?
Douglas Evan Godshall (executive at Shockwave Medical Inc., SWAV) reported that they sold 5,000 shares for $939K at an average $187.80, and acquired 5,000 shares at $3.42 on Dec 15, 2023. After these transactions the filing shows 141,057 shares held directly.
How many SWAV shares does Godshall hold after this filing?
The filing shows 141,057 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this SWAV insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for SWAV
Earlier insider filings at SWAV
- Dec 13, 2023Zacharias Isaac covered exercise/tax liability with 542 shares, decreasing direct ownership by 1% to 42,148 units (SEC Form 4)
- Dec 13, 2023Francis Laura gifted 497 shares and received a gift of 497 shares, decreasing direct ownership by 29% to 1,233 units (SEC Form 4)
- Dec 13, 2023Zacharias Isaac covered exercise/tax liability with 1,178 shares, increasing direct ownership by 30% to 89,843 units (SEC Form 4)
- Dec 12, 2023Puckett Dan sold $34,776 worth of shares (200 units at $173.88), decreasing direct ownership by 0.69% to 28,784 units (SEC Form 4)
- Dec 9, 2023Phung Trinh sold $34,841 worth of shares (203 units at $171.63), decreasing direct ownership by 0.69% to 29,037 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2019
Follow SWAV and get a push notification the moment its next story breaks.